FDA RECALL: A September recall has been issued for more than 13,000 bottles of chlorthalidone tablets after the product failed dissolution testing, which may reduce the medication’s effectiveness.
The recall covers chlorthalidone tablets, USP, 25 mg, packaged in 100‑count bottles and labeled as Rx only.
The affected lot is Batch RISA24002 with an expiration date of April 2027, distributed under NDC 64980‑599‑01 and manufactured by Inventia Healthcare Limited.
The recall is classified as a Class II event, indicating that temporary or medically reversible health effects are possible, though the risk of serious outcomes is considered remote. Patients are advised to check bottle labels for matching lot and NDC information. Pharmacists can confirm whether a bottle is included in the recall and assist with replacement or return procedures.
Patients should not discontinue the medication without consulting their healthcare provider.
© 2026 CoastalCarolinaNews.com. All rights reserved.
Be the first to comment